Dexmethylphenidate: 7 things you should know
Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 20, 2023.
1. How it works
- Dexmethylphenidate is a component of racemic methylphenidate (methylphenidate contains two isomers: d-threo-methylphenidate [also called dexmethylphenidate] and l-threo-methylphenidate). The d-isomer is much more potent than the l-isomer. Dexmethylphenidate is the more active isomer of the two and it may be used to treat Attention Deficit Hyperactivity Disorder (ADHD).
- Experts aren't exactly sure how dexmethylphenidate works to treat ADHD but think it affects the reuptake of both dopamine and norepinephrine, two neurotransmitters.
- Dexmethylphenidate is called a central nervous system (CNS) stimulant.
2. Upsides
- Used in the treatment of ADHD in adults and children over the age of six.
- Dexmethylphenidate should be used in addition to other treatment modalities such as psychotherapy, education, and social integration advice.
- Dexmethylphenidate is available as immediate-release tablets and extended-release capsules.
- The recommended starting dose for pediatric patients not currently taking racemic methylphenidate is 2.5mg twice daily.
- Generic dexmethylphenidate is available.
3. Downsides
If you are between the ages of 18 and 60, take no other medication or have no other medical conditions, side effects you are more likely to experience include:
- A headache, abdominal pain, decreased appetite, nausea, nervousness, and fever. May also cause muscle twitching, sleeplessness, increased blood pressure, and a fast heartbeat.
- Dexmethylphenidate is associated with abuse and dependence. The risk of dependence is greater with the extended-release capsules and in people with a history of drug dependence and alcoholism. Psychotic episodes have also been reported, particularly with overuse. Assess a person's risk of abuse before prescribing dexmethylphenidate and monitor for signs of abuse and dependence during treatment. Periodically evaluate the need for dexmethylphenidate tablets.
- May impair judgment or reaction skills. Exercise caution before driving or operating machinery until the full effects of dexmethylphenidate are known.
- Screen people before prescribing dexmethylphenidate for the presence of cardiac disease. Ask about their cardiovascular history and family history of sudden death or ventricular arrhythmia, and conduct a physical exam.
- May aggravate preexisting symptoms of anxiety, tension, and agitation. May precipitate the emergence of psychotic thoughts such as hallucinations, delusions, or mania in people without a prior history of such thoughts. Discontinuation of treatment may be appropriate.
- May not be suitable for people with certain heart conditions, glaucoma, a history of tics or a family history of Tourette's syndrome, certain psychiatric disorders, a history of alcohol overuse, or drug dependence. Has been associated with an increased risk of sudden death in people with structural heart abnormalities or other serious heart problems; may also increase the risk of a stroke or heart attack in adults.
- May increase the risk of seizures and peripheral circulatory problems and cause visual problems.
- Reports indicate some temporary slowing of growth may occur when long-term dexmethylphenidate is given to children. Doctors should monitor height and weight and consider treatment interruption if growth suppression is suspected.
- Rare cases of priapism (painful erections lasting more than 6 hours) have been reported.
- May interact with some other medications including monoamine oxidase inhibitors (MAO inhibitors) (do not use within 14 days of discontinuation of an MAO inhibitor), halogenated anesthetics (do not take dexmethylphenidate on the day of surgery), coumarin anticoagulants, anticonvulsants, antidepressants, and drugs used to treat high blood pressure.
- Alcohol may contribute to the side effects of dexmethylphenidate and should be avoided.
- Classified as a Schedule II controlled substance, meaning that dexmethylphenidate has a high potential for abuse. Keep personal supplies of dexmethylphenidate in a safe place, out of view of potential drug seekers.
- Tablets should be administered twice daily, at least 4 hours apart.
- Should not be used in children under the age of six.
- Only use in pregnant women if the potential benefits justify the risks. There are no adequate controlled studies in humans of use during pregnancy, animal studies have not shown any evidence of a teratogenic effect; however, delayed fetal skeletal ossification and post-weaning body weight gain in male offspring have been observed. It is unknown if dexmethylphenidate is excreted into human breast milk, and a breastfeeding infant should be monitored if dexmethylphenidate tablets are administered to a breastfeeding woman.
Note: In general, seniors or children, people with certain medical conditions (such as liver or kidney problems, heart disease, diabetes, seizures) or people who take other medications are more at risk of developing a wider range of side effects. View complete list of side effects
4. Bottom Line
- Dexmethylphenidate improves symptoms of ADHD but carries with it a risk of dependence. It is twice as potent as methylphenidate.
5. Tips
- Immediate-release dexmethylphenidate tablets are usually taken twice daily, at least four hours apart. Ensure that the last dose is not taken any later than 6 pm. Extended-release capsules are taken once daily, in the morning.
- May be taken with or without food.
- Take exactly as directed by your doctor and never increase the dosage without his or her advice.
- Swallow extended-release capsules whole with a glass of water; do not chew, divide, or crush. For people who have difficulty swallowing, the capsule may be opened and the contents mixed with applesauce then swallowed immediately.
- Do not drive or operate machinery if dexmethylphenidate impairs your judgment or reaction times.
- Seek medical advice if any new numbness, pain, skin color change, sensitivity, or unexplained wounds occur in fingers or toes.
- Avoid alcohol because it may potentiate the side effects of dexmethylphenidate.
- Seek urgent medical attention if you develop any chest pain, shortness of breath, or if fainting occurs while taking dexmethylphenidate. Call your doctor if you have any new or worsening mental symptoms such as hallucinations, delusions, or hearing voices. Seek medical advice if symptoms persist or worsen despite treatment.
- Seek medical advice if your fingers or toes become numb or painful, the skin changes color, or breaks down. Seek emergency attention if painful, prolonged erections occur.
- Tell your doctor if you are pregnant, intending to become pregnant, or breastfeeding because dexmethylphenidate may not be suitable for you.
6. Response and effectiveness
- Initial peak concentrations of dexmethylphenidate are reached within an hour to an hour and a half.
- Some symptom relief may be noticed after one to two hours; however, it may take up to two weeks before the full effects of dexmethylphenidate are seen.
- Extended-release capsules have a two-phase release system. Half the dose is provided in immediate-release beads and the other half in delayed-release beads. One single extended-release capsule provides the same amount of active ingredient as two immediate-release tablets given four hours apart.
- Dexmethylphenidate is approximately twice as potent as methylphenidate.
7. Interactions
Medicines that interact with dexmethylphenidate may either decrease its effect, affect how long it works, increase side effects, or have less of an effect when taken with dexmethylphenidate. An interaction between two medications does not always mean that you must stop taking one of the medications; however, sometimes it does. Speak to your doctor about how drug interactions should be managed.
Common medications that may interact with dexmethylphenidate include:
- anticoagulants (blood thinners) such as apixaban, dabigatran, heparin, or warfarin
- anticonvulsants, such as phenytoin, phenobarbital, or primidone
- antidepressants, such as amitriptyline, amoxapine, citalopram, clomipramine, desipramine, doxepin, fluoxetine, fluvoxamine, imipramine, isocarboxazid, nortriptyline, paroxetine, phenelzine, protriptyline, sertraline, trimipramine, and venlafaxine. Do not use within 14 days of discontinuation of an MAO inhibitor
- decongestants, such as phenylephrine or pseudoephedrine
- high blood pressure medications, such as ACE Inhibitors, alpha-blockers, ARBs, beta-blockers, calcium channel blockers, or diuretics
- others, such as halogenated anesthetics (do not take dexmethylphenidate on the day of surgery) or guanfacine.
Avoid drinking alcohol or taking illegal or recreational drugs while taking dexmethylphenidate. Antacids should not be taken with the extended-release form of dexmethylphenidate.
Note that this list is not all-inclusive and includes only common medications that may interact with dexmethylphenidate. You should refer to the prescribing information for dexmethylphenidate for a complete list of interactions.
More about dexmethylphenidate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (294)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: CNS stimulants
- Breastfeeding
- En español
Patient resources
- Dexmethylphenidate drug information
- Dexmethylphenidate Tablets
- Dexmethylphenidate Extended-Release Capsules
Other brands
Professional resources
- Dexmethylphenidate Hydrochloride and Serdexmethylphenidate Chloride monograph
- Dexmethylphenidate (FDA)
- Dexmethylphenidate ER Capsule (FDA)
Other brands
Related treatment guides
References
- Dexmethylphenidate. Revised 07/2023. Lannett Company, Inc. https://www.drugs.com/pro/dexmethylphenidate.html
Further information
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use dexmethylphenidate only for the indication prescribed.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Copyright 1996-2025 Drugs.com. Revision date: November 19, 2023.